 MOORESTOWN, N.J., Dec. 17, 2020 GLOBE NEWSWIRE -- Tabula Rasa HealthCare, Inc. TRHC NASDAQ: TRHC, a healthcare technology company advancing the field of medication safety, announces today it has entered into a partnership with Physiomics plc AIM: PYC, the oncology consultancy using mathematical models to support the development of cancer treatment regimens and personalized medicine solutions. Through this initiative, Physiomics personalized docetaxel model will be integrated into TRHCs market-leading precision dosing solution, DoseMeRx. Both parties expect positive feedback from this initial trial with the next step being a commercial agreement. 